Scenario

Insurer Renewal Questionnaire

What if renewal forms start asking about AI?

Insurer and PMI renewal questionnaires are increasingly touching on AI use, data protection and clinical risk management - even where AI is not named directly.

A clinic that cannot answer clearly may be less prepared for renewal discussions.

The scenario

Your insurer's renewal form asks whether AI tools process patient data and whether DPIA or clinical safety review status is clear.

Your ambient scribe has been in use for six months, but the DPIA status, vendor evidence file and clinical safety review position are not yet documented in one place.

Evidence areas renewal questions may cover

  • Whether AI tools are used in diagnostics, documentation or triage
  • Whether DPIA status and clinical safety review status are clear
  • Where AI vendors host data and how international transfer risks are reviewed
  • Whether AI policies and staff training are in place
  • Cyber controls, data protection governance and clinical risk management where AI tools support clinical or administrative workflows

What ELSA AI does

  • Produces an MDO, PMI and Insurer Disclosure Readiness Note identifying which governance evidence exists, what is missing, and what may need clarification with the insurer or adviser
  • Maps vendor data position evidence, including data residency, DPAs, sub-processors, security assurance and retention indicators
  • Produces disclosure-readiness templates the clinic can review and use when engaging its insurer directly

ELSA AI does not provide insurer coverage advice. We do not determine whether an insurer will or will not pay a claim, or how a specific AI use affects coverage. Final disclosure decisions and insurer conversations remain with the clinic and its indemnity providers.

Can ELSA AI tell us whether AI use affects our insurance cover?

No. ELSA AI does not provide insurer coverage advice and does not determine how an insurer will respond to a specific AI use case.

We help clinics organise the evidence likely to be relevant to renewal or disclosure discussions, including AI tool use, patient data exposure, vendor evidence, DPIA status, clinical oversight and staff guidance.

Final disclosure decisions and insurer conversations remain with the clinic and its insurance advisers or providers.

Advisory governance support only. Not legal advice, insurer coverage advice, CQC certification, ICO approval or clinical safety case sign-off.